Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-02-25

FDA Approved: ALTAVERA — Supplemental Application (Xiromed, LLC.)

View source ↗

Summary

FDA approved a supplemental application for ALTAVERA, a combined oral contraceptive containing levonorgestrel and ethinyl estradiol, submitted by Xiromed, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALTAVERA (LEVONORGESTREL AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for ALTAVERA (LEVONORGESTREL AND ETHINYL ESTRADIOL)